These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 26311473)
1. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose. Wójtowicz M; Jarek A; Chajewska K; Turek-Lepa E; Kwiatkowska D J Pharm Biomed Anal; 2015 Nov; 115():523-33. PubMed ID: 26311473 [TBL] [Abstract][Full Text] [Related]
2. N,N-dimethyl-2-phenylpropan-1-amine quantification in urine: application to excretion study following single oral dietary supplement dose. Wójtowicz M; Jarek A; Chajewska K; Kwiatkowska D Anal Bioanal Chem; 2016 Jul; 408(18):5041-7. PubMed ID: 27178556 [TBL] [Abstract][Full Text] [Related]
3. Designer phenethylamines routinely found in human urine: 2-ethylamino-1-phenylbutane and 2-amino-1-phenylbutane. Uralets V; App M; Rana S; Morgan S; Ross W J Anal Toxicol; 2014 Mar; 38(2):106-9. PubMed ID: 24451085 [TBL] [Abstract][Full Text] [Related]
4. N,N-dimethyl-2-phenylpropan-1-amine - new designer agent found in athlete urine and nutritional supplement. Kwiatkowska D; Wójtowicz M; Jarek A; Goebel C; Chajewska K; Turek-Lepa E; Pokrywka A; Kazlauskas R Drug Test Anal; 2015 Apr; 7(4):331-5. PubMed ID: 25355281 [TBL] [Abstract][Full Text] [Related]
5. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102 [TBL] [Abstract][Full Text] [Related]
6. Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control. Brooker L; Cawley A; Kazlauskas R; Goebel C; George A Drug Test Anal; 2012 Dec; 4(12):951-61. PubMed ID: 22987608 [TBL] [Abstract][Full Text] [Related]
7. Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro-in vivo correlation of metabolic profiles and development of LC-TOF-MS method. Kobayashi M; Pelander A; Ketola RA; Leinonen A; Kuuranne T Drug Test Anal; 2015 Feb; 7(2):89-94. PubMed ID: 24687931 [TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric detection of peginesatide in human urine in doping control analysis. Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a GC-C-IRMS method for the confirmation analysis of pseudo-endogenous glucocorticoids in doping control. de la Torre X; Curcio D; Colamonici C; Molaioni F; Cilia M; Botrè F Drug Test Anal; 2015; 7(11-12):1071-8. PubMed ID: 26607312 [TBL] [Abstract][Full Text] [Related]
10. LC-MS-MS analysis of dietary supplements for N-ethyl-α-ethyl-phenethylamine (ETH), N, N-diethylphenethylamine and phenethylamine. ElSohly MA; Gul W J Anal Toxicol; 2014 Mar; 38(2):63-72. PubMed ID: 24344073 [TBL] [Abstract][Full Text] [Related]
11. Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control. Brailsford AD; Gavrilović I; Ansell RJ; Cowan DA; Kicman AT Drug Test Anal; 2012 Dec; 4(12):962-9. PubMed ID: 22761127 [TBL] [Abstract][Full Text] [Related]
12. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry. Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280 [TBL] [Abstract][Full Text] [Related]
13. Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for "in competition" anti-doping analysis. Strano-Rossi S; Colamonici C; Botrè F Anal Chim Acta; 2008 Jan; 606(2):217-22. PubMed ID: 18082653 [TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls. Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079 [TBL] [Abstract][Full Text] [Related]
15. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control. Brooker L; Parr MK; Cawley A; Flenker U; Howe C; Kazlauskas R; Schänzer W; George A Drug Test Anal; 2009 Nov; 1(11-12):587-95. PubMed ID: 20355175 [TBL] [Abstract][Full Text] [Related]
16. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism. Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of ibuprofen and its metabolites in complex equine urine matrices by GC-EI-MS in excretion study in view of doping control. Waraksa E; Wójtowicz-Zawadka M; Kwiatkowska D; Jarek A; Małkowska A; Wrzesień R; Namieśnik J J Pharm Biomed Anal; 2018 Apr; 152():279-288. PubMed ID: 29453024 [TBL] [Abstract][Full Text] [Related]
18. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry. Rzeppa S; Heinrich G; Hemmersbach P Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of urinary glycerol levels for doping control purposes using gas chromatography-mass spectrometry. Thevis M; Guddat S; Flenker U; Schänzer W Eur J Mass Spectrom (Chichester); 2008; 14(3):117-25. PubMed ID: 18708691 [TBL] [Abstract][Full Text] [Related]
20. Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control. Parr MK; Fusshöller G; Schlörer N; Opfermann G; Piper T; Rodchenkov G; Schänzer W Rapid Commun Mass Spectrom; 2009 Jan; 23(2):207-18. PubMed ID: 19089863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]